1584 related articles for article (PubMed ID: 28969548)
1. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
[TBL] [Abstract][Full Text] [Related]
2. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
[TBL] [Abstract][Full Text] [Related]
3. Two-dimensional cancer theranostic nanomaterials: Synthesis, surface functionalization and applications in photothermal therapy.
Murugan C; Sharma V; Murugan RK; Malaimegu G; Sundaramurthy A
J Control Release; 2019 Apr; 299():1-20. PubMed ID: 30771414
[TBL] [Abstract][Full Text] [Related]
4. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
Tripathi P; Shukla P; Bieberich E
Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
[TBL] [Abstract][Full Text] [Related]
5. 2D Nanomaterials for Cancer Theranostic Applications.
Cheng L; Wang X; Gong F; Liu T; Liu Z
Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated nanomaterials for targeted cancer theranostics.
Chan YC; Hsiao M
Nanomedicine (Lond); 2017 Sep; 12(18):2153-2159. PubMed ID: 28814163
[TBL] [Abstract][Full Text] [Related]
7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
8. Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer.
Truffi M; Fiandra L; Sorrentino L; Monieri M; Corsi F; Mazzucchelli S
Pharmacol Res; 2016 May; 107():57-65. PubMed ID: 26968122
[TBL] [Abstract][Full Text] [Related]
9. Recent Progress in 808 nm Excited Upconversion Nanomaterials as Multifunctional Nanoprobes for Visualized Theranostics in Cancers.
Zeng L; Wu D; Tian Y; Pan Y; Wu A; Zhang J; Lu G
Curr Med Chem; 2018; 25(25):2954-2969. PubMed ID: 28322153
[TBL] [Abstract][Full Text] [Related]
10. Biomedical Applications of Nanomaterials as Therapeutics.
Ng CT; Baeg GH; Yu LE; Ong CN; Bay BH
Curr Med Chem; 2018; 25(12):1409-1419. PubMed ID: 28393698
[TBL] [Abstract][Full Text] [Related]
11. A Review of Theranostics Applications and Toxicities of Carbon Nanomaterials.
Gupta N; Rai DB; Jangid AK; Kulhari H
Curr Drug Metab; 2019; 20(6):506-532. PubMed ID: 30251600
[TBL] [Abstract][Full Text] [Related]
12. Theranostic applications of carbon nanomaterials in cancer: Focus on imaging and cargo delivery.
Chen D; Dougherty CA; Zhu K; Hong H
J Control Release; 2015 Jul; 210():230-45. PubMed ID: 25910580
[TBL] [Abstract][Full Text] [Related]
13. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
[TBL] [Abstract][Full Text] [Related]
14. Lanthanide-doped hollow nanomaterials as theranostic agents.
Kang X; Li C; Cheng Z; Ma P; Hou Z; Lin J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(1):80-101. PubMed ID: 24227795
[TBL] [Abstract][Full Text] [Related]
15. Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
Farahavar G; Abolmaali SS; Gholijani N; Nejatollahi F
Biomater Sci; 2019 Oct; 7(10):4000-4016. PubMed ID: 31355391
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
[TBL] [Abstract][Full Text] [Related]
17. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.
Ahmad J; Rizwanullah M; Suthar T; Albarqi HA; Ahmad MZ; Vuddanda PR; Khan MA; Jain K
Crit Rev Ther Drug Carrier Syst; 2022; 39(6):1-44. PubMed ID: 35997100
[TBL] [Abstract][Full Text] [Related]
18. Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy.
Peng F; Su Y; Zhong Y; Fan C; Lee ST; He Y
Acc Chem Res; 2014 Feb; 47(2):612-23. PubMed ID: 24397270
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnological selection.
Demming A
Nanotechnology; 2013 Jan; 24(2):020201. PubMed ID: 23242125
[TBL] [Abstract][Full Text] [Related]
20. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
Sharma R; Mody N; Agrawal U; Vyas SP
Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
